Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Thomas Jefferson University
Endo Pharmaceuticals
The Ottawa Hospital
Ottawa Heart Institute Research Corporation
Wake Forest University Health Sciences
NYU Langone Health
University of Southern California
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
TC Erciyes University
Fox Chase Cancer Center